INTARCIA THERAPEUTICS, INC of HAYWARD, CA, a company, filed a Form D amendment with the SEC on 2020-01-14. The offering totals $280.0M, of which $198.5M was reported sold. Industry: Biotechnology.
Showing 25 of 75 people.
| Name | Role | Location |
|---|---|---|
| PATRICK CONWAY | Director | TACOMA, WA |
| Kurt Graves | Director | Hayward, CA |
| Bob Kerrey | Director | Boston, MA |
| Bryan Roberts | Director | Boulder, CO |
| Jim Rosenthal | Director | New York, NY |
| Gino Santini | Director | Cambridge, MA |
| Jay Skyler | Director | Miami Beach, FL |
| Nancy Thornberry | Director | Boston, MA |
| Paul Feldman | Executive Officer | Wilmington, DE |
| Fred Fiedorek | Executive Officer | Boston, MA |
| Kurt Graves | Executive Officer | Hayward, CA |
| Raymond Keane | Executive Officer | Boston, MA |
| David Spellman | Executive Officer | Boston, MA |
| Anders Vinther | Executive Officer | Boston, MA |
| Thane Wettig | Executive Officer | Boston, MA |
| Michael Williams | Executive Officer | New York, NY |
| John Yee | Executive Officer | Sarasota, FL |
| James Ahlers | Executive Officer | Hayward, CA |
| Bryan L Roberts | Director | Pleasanton, CA |
| David Franklin | Executive Officer | Gainesville, FL |
| Jay Smith | Executive Officer | Davis, CA |
| Barbara G McClung | Executive Officer | Berkeley, CA |
| Ed Mathers | Director | TIMONIUM, MD |
| Thomas Alessi | Executive Officer | Boston, MA |
| Anthony Hurley | Executive Officer | Boston, MA |
Showing 15 of 18 filings.
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2019-03-12 | D | $150.0M | $73.1M |
| 2017-08-04 | D/A | $850.0M | $524.6M |
| 2017-04-03 | D/A | $650.0M | $475.7M |
| 2017-01-13 | D | $4K | $4K |
| 2017-01-06 | D/A | $650.0M | $390.7M |
| 2016-09-15 | D | $600.0M | $184.4M |
| 2014-04-07 | D | $200.0M | $200.0M |
| 2012-11-29 | D | $160.0M | $155.9M |
| 2012-11-29 | D | $7.9M | $7.9M |
| 2012-11-29 | D | $699K | $699K |
| 2012-08-30 | D/A | $47.5M | $45.8M |
| 2012-08-22 | D | $7.3M | $7.3M |
| 2011-08-25 | D/A | $44.0M | $40.3M |
| 2011-06-10 | D/A | $29.0M | $27.0M |
| 2010-09-07 | D | $15.0M | $5.0M |